These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22320812)
1. Impact of using linear optimization models in dose planning for HDR brachytherapy. Holm A; Larsson T; Carlsson Tedgren A Med Phys; 2012 Feb; 39(2):1021-8. PubMed ID: 22320812 [TBL] [Abstract][Full Text] [Related]
2. Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs. Alterovitz R; Lessard E; Pouliot J; Hsu IC; O'Brien JF; Goldberg K Med Phys; 2006 Nov; 33(11):4012-9. PubMed ID: 17153381 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization. Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425 [TBL] [Abstract][Full Text] [Related]
4. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy. Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432 [TBL] [Abstract][Full Text] [Related]
5. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study. Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874 [TBL] [Abstract][Full Text] [Related]
6. The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy. Smith RL; Panettieri V; Lancaster C; Mason N; Franich RD; Millar JL Australas Phys Eng Sci Med; 2015 Mar; 38(1):55-61. PubMed ID: 25481387 [TBL] [Abstract][Full Text] [Related]
7. Mixed integer programming improves comprehensibility and plan quality in inverse optimization of prostate HDR brachytherapy. Gorissen BL; den Hertog D; Hoffmann AL Phys Med Biol; 2013 Feb; 58(4):1041-57. PubMed ID: 23363622 [TBL] [Abstract][Full Text] [Related]
8. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices. Siauw T; Cunha A; Atamtürk A; Hsu IC; Pouliot J; Goldberg K Med Phys; 2011 Jul; 38(7):4045-51. PubMed ID: 21859003 [TBL] [Abstract][Full Text] [Related]
9. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy. Morton GC; Sankreacha R; Halina P; Loblaw A Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356 [TBL] [Abstract][Full Text] [Related]
10. Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy. Balvert M; Gorissen BL; den Hertog D; Hoffmann AL Phys Med Biol; 2015 Jan; 60(2):537-48. PubMed ID: 25549084 [TBL] [Abstract][Full Text] [Related]
11. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources. Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569 [TBL] [Abstract][Full Text] [Related]
12. Sub-second high dose rate brachytherapy Monte Carlo dose calculations with bGPUMCD. Hissoiny S; D'Amours M; Ozell B; Despres P; Beaulieu L Med Phys; 2012 Jul; 39(7):4559-67. PubMed ID: 22830787 [TBL] [Abstract][Full Text] [Related]
13. A linear source table to determine the treatment times for cylindrical applicators used in high-dose rate brachytherapy. Sha RL; Reddy PY; Sahoo N Brachytherapy; 2011; 10(3):249-52. PubMed ID: 20933480 [TBL] [Abstract][Full Text] [Related]
14. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy. Liu Y; Flynn RT; Kim Y; Wu X Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623 [TBL] [Abstract][Full Text] [Related]
15. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance. Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606 [TBL] [Abstract][Full Text] [Related]
16. A linear programming model for optimizing HDR brachytherapy dose distributions with respect to mean dose in the DVH-tail. Holm Å; Larsson T; Tedgren ÅC Med Phys; 2013 Aug; 40(8):081705. PubMed ID: 23927302 [TBL] [Abstract][Full Text] [Related]
17. Fast mixed integer optimization (FMIO) for high dose rate brachytherapy. Antaki M; L Deufel C; Enger SA Phys Med Biol; 2020 Dec; 65(21):215005. PubMed ID: 33283763 [TBL] [Abstract][Full Text] [Related]
18. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Edmundson GK; Yan D; Martinez AA Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1257-63. PubMed ID: 7493850 [TBL] [Abstract][Full Text] [Related]